Dr. Prabhat Ranjan is a dedicated Medical Oncologist with over years of experience in delivering advanced and personalized cancer care. He specializes in administering Chemotherapy, immunotherapy. Targeted Therapy, and Hormone Therapy, along with procedures like Bone Marrow Aspiration, Biopsy, and Pleural Tapping.
.png)
A cancer diagnosis often brings an immediate focus on treatment—chemotherapy, radiation therapy, surgery, targeted therapy, or immunotherapy. For younger patients and anyone who may want children in the future, however, another important conversation should happen as early as possible: Could cancer treatment affect fertility?
Some cancer treatments can temporarily or permanently affect the reproductive system. The level of risk depends on factors such as the type of cancer, treatment used, treatment dose, age, baseline fertility, and the reproductive organs exposed to treatment. Fortunately, fertility-preservation options are available for many patients.
Current ASCO guidance recommends discussing reproductive risks and fertility-preservation options before cancer-directed treatment whenever possible and referring interested or uncertain patients to reproductive specialists.
Cancer itself does not always cause infertility, but some treatments can affect the ovaries, eggs, testes, sperm production, uterus, or the hormones involved in reproduction.
Chemotherapy may damage eggs or sperm-producing cells. The degree of risk varies according to the drugs and doses used.
Radiation therapy can affect fertility when reproductive organs or areas involved in hormone production are exposed to radiation.
Surgery involving reproductive organs may also affect the ability to conceive or carry a pregnancy.
The risk is highly individual. This is why patients should not assume either that infertility is inevitable or that their fertility will definitely remain unaffected.
A discussion with the best medical oncologist in Greater Noida can help patients understand how their proposed cancer treatment may affect reproductive health and whether consultation with a fertility specialist should occur before treatment begins.
Ideally, fertility should be discussed before cancer treatment starts.
Certain preservation methods need to be completed before chemotherapy, radiation, or surgery. ASCO's updated guidance emphasizes discussing fertility-preservation approaches before cancer-directed therapy and referring interested patients—or even uncertain patients—to reproductive specialists.
However, cancer treatment should not be delayed without careful medical consideration.
The oncology and fertility teams need to coordinate closely. The urgency of cancer treatment, type and stage of cancer, fertility-preservation method, and time required for the procedure all influence what is feasible.
Several established approaches may be considered depending on age, cancer type, treatment plan, ovarian reserve, available time, and personal circumstances.
Egg freezing, or oocyte cryopreservation, is an established fertility-preservation method.
The ovaries are stimulated using fertility medications so that multiple eggs can mature. These eggs are then retrieved and frozen for potential future use.
The process generally requires coordination between the fertility specialist and oncology team. Importantly, no fertility-preservation technique can guarantee a future pregnancy.
Embryo cryopreservation involves collecting eggs and fertilizing them with sperm in the laboratory before freezing the resulting embryos.
Like egg freezing, it generally involves ovarian stimulation and egg retrieval.
The National Cancer Institute notes that doctors and fertility specialists can work together to coordinate fertility preservation with the timing of cancer treatment.
In selected patients, ovarian tissue may be surgically removed and frozen for possible future use.
The 2025 ASCO guideline includes ovarian tissue cryopreservation among established fertility-preservation methods that may be offered to appropriate female patients.
The suitability of this approach depends on the individual clinical situation and should be assessed by specialists experienced in oncofertility.
When radiation therapy is planned near the pelvis, surgery may sometimes be performed to move the ovaries away from the planned radiation field.
This procedure is known as ovarian transposition.
It does not eliminate all fertility risks but may be considered for selected patients. ASCO includes ovarian transposition among fertility-preservation approaches for appropriate patients.
For post-pubertal male patients, sperm cryopreservation or sperm banking is an established fertility-preservation approach.
Semen samples are collected before cancer treatment and stored for potential future use in assisted reproductive techniques.
ASCO recommends offering sperm cryopreservation before cancer-directed treatment. For patients unable to provide a semen sample, other specialist approaches may sometimes be considered.
Talking with the best medical oncologist in Greater Noida before starting treatment can help identify whether the planned therapy carries a meaningful fertility risk and facilitate timely referral to an appropriate reproductive specialist.
Fertility preservation is also relevant to pediatric and adolescent cancer care.
Options depend heavily on whether the child has reached puberty.
For post-pubertal adolescents, some established adult preservation methods may be possible. In younger children, options are more specialized.
For example, ASCO's current guidance states that testicular tissue cryopreservation in prepubertal males remains experimental and should be offered only in the context of a clinical trial.
These conversations can understandably be difficult for families, but discussing future reproductive health before treatment may preserve options that could otherwise be lost.
This is one of the most important concerns patients have.
The answer depends on the cancer and preservation method.
Some cancers require treatment to begin urgently, while other clinical situations may allow sufficient time for a fertility-preservation procedure. No patient should independently postpone cancer treatment to undergo fertility treatment.
Instead, the oncologist and reproductive specialist should jointly determine what is medically appropriate.
The NCI specifically advises that the healthcare team can guide patients on the timing of fertility procedures and whether any delay in cancer treatment is appropriate.
No. Fertility after cancer treatment varies substantially.
Some patients may experience temporary changes and later recover reproductive function. Others may experience permanent infertility.
For women, factors such as age, ovarian reserve, treatment type, surgical extent, and treatment dose can influence the risk.
Similarly, sperm production after treatment may recover in some men but not others.
This uncertainty is one reason fertility discussions are most valuable before treatment whenever circumstances allow.
No fertility-preservation procedure provides a 100% guarantee.
Future success depends on several factors, including age at preservation, number and quality of eggs or embryos stored, sperm quality, underlying reproductive health, cancer treatment, and future health status.
The American Cancer Society emphasizes that patients should understand both the potential benefits and limitations of fertility-preservation options.
The goal is to preserve possibilities for the future—not promise a particular outcome.
Patients should not assume that infertility caused by treatment means pregnancy cannot occur during cancer therapy.
Certain cancer treatments can harm a developing fetus, so patients should discuss contraception and pregnancy planning with their cancer care team. The American Cancer Society advises patients to discuss birth control during and after treatment because some cancer therapies can harm a developing pregnancy.
Contraceptive recommendations should be individualized according to the cancer diagnosis and treatment.
Patients who may want children in the future should consider discussing fertility early in treatment planning.
Useful questions include:
Even patients who are unsure whether they want children in the future may benefit from having this conversation.
Fertility preservation is most effective when oncology and reproductive specialists communicate closely.
Cancer treatment remains the priority, but future quality of life—including reproductive goals—also matters. The updated ASCO recommendations emphasize reproductive-risk counseling at diagnosis and during survivorship, reflecting the importance of considering fertility across the cancer journey.
The best medical oncologist in Greater Noida can help patients understand the potential fertility impact of their cancer treatment and coordinate appropriate specialist referrals without losing sight of the urgency and goals of cancer therapy.
Patients who have already begun or completed cancer treatment should not assume that it is too late to discuss reproductive health.
ASCO's updated guideline recognizes a role for fertility counseling during survivorship and notes that post-treatment fertility preservation may be considered in appropriate circumstances.
A fertility specialist can assess reproductive function and discuss realistic options based on previous treatment and current health.
Fertility may not be the first concern that comes to mind after a cancer diagnosis, but for many patients it is an important part of long-term quality of life.
Chemotherapy, radiation, surgery, and other cancer treatments can affect reproductive health, but options such as egg freezing, embryo freezing, sperm banking, ovarian tissue cryopreservation, and selected surgical approaches may help preserve future possibilities.
The key is early communication. Patients should ideally discuss fertility risks before cancer treatment begins, while recognizing that cancer treatment should never be delayed without appropriate medical guidance.
Working with the best medical oncologist in Greater Noida and an experienced fertility specialist can help patients balance effective cancer treatment with their future reproductive goals.
Yes. Ideally, fertility risks and available preservation options should be discussed before cancer-directed treatment begins.
Yes. Egg freezing is an established option for suitable patients.
Yes. Sperm cryopreservation is an established fertility-preservation method for post-pubertal males.
It may return in some patients, but infertility can be permanent in others. The risk depends on several individual and treatment-related factors.
No. It can preserve future reproductive options, but no fertility-preservation method guarantees a successful pregnancy.
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)